Capital International Investors - VIR BIOTECHNOLOGY INC ownership

VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 166 filers reported holding VIR BIOTECHNOLOGY INC in Q2 2021. The put-call ratio across all filers is 0.78 and the average weighting 0.3%.

Quarter-by-quarter ownership
Capital International Investors ownership history of VIR BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2023$2,421,208
-61.8%
258,4000.0%0.00%
-50.0%
Q2 2023$6,338,552
+5.4%
258,4000.0%0.00%0.0%
Q1 2023$6,012,968
-8.1%
258,4000.0%0.00%0.0%
Q4 2022$6,540,104
+31.3%
258,4000.0%0.00%
+100.0%
Q3 2022$4,982,000
-92.6%
258,400
-90.3%
0.00%
-94.4%
Q2 2022$67,768,000
-39.1%
2,660,682
-38.5%
0.02%
-28.0%
Q1 2022$111,355,000
-51.7%
4,329,516
-21.4%
0.02%
-49.0%
Q4 2021$230,518,000
-39.3%
5,505,566
-36.9%
0.05%
-43.7%
Q3 2021$379,654,000
-32.2%
8,723,656
-26.3%
0.09%
-32.0%
Q2 2021$559,986,000
-7.6%
11,844,033
+0.2%
0.13%
-16.3%
Q1 2021$606,153,000
+100.3%
11,822,763
+4.6%
0.15%
+84.3%
Q4 2020$302,636,000
-21.9%
11,300,804
+0.2%
0.08%
-30.8%
Q3 2020$387,349,000
+764.0%
11,283,094
+931.1%
0.12%
+700.0%
Q2 2020$44,834,000
+19.6%
1,094,3050.0%0.02%0.0%
Q1 2020$37,502,000
+203.3%
1,094,305
+11.3%
0.02%
+275.0%
Q4 2019$12,365,000983,3000.00%
Other shareholders
VIR BIOTECHNOLOGY INC shareholders Q2 2021
NameSharesValueWeighting ↓
Bill & Melinda Gates Foundation 1,559,142$14,609,16117.42%
SB INVESTMENT ADVISERS (UK) LTD 16,684,041$156,329,4641.29%
Octagon Capital Advisors LP 325,050$3,045,7190.47%
SECTOR GAMMA AS 148,538$1,391,8010.36%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 1,345,635$12,608,6000.31%
ALGERT GLOBAL LLC 449,685$4,2140.20%
Quantamental Technologies LLC 18,519$173,5230.16%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 47,000$439,9200.15%
DUALITY ADVISERS, LP 123,871$1,160,6710.14%
Empowered Funds, LLC 385,135$3,608,7150.11%
View complete list of VIR BIOTECHNOLOGY INC shareholders